Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GLRX3 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GLRX3 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of GLRX3 mRNA | decreases expression | 16788091
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of GLRX3 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GLRX3 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of GLRX3 mRNA | increases expression | 20458559
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of GLRX3 mRNA | decreases expression | 20678512
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of GLRX3 mRNA | increases expression | 15336504
|
D002118 |
Calcium |
GLRX3 protein affects the susceptibility to Calcium | affects response to substance | 16809552
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GLRX3 mRNA | affects cotreatment|affects expression | 17602206
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in increased expression of GLRX3 mRNA | increases expression | 17654400
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GLRX3 mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GLRX3 mRNA | affects cotreatment|affects expression | 17602206
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GLRX3 mRNA | increases expression | 19400957 17942748 16174780
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GLRX3 mRNA | increases expression | 16174780 19400957
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of GLRX3 mRNA | increases expression | 18035473
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of GLRX3 mRNA | increases expression | 17317680
|
C051890 |
irinotecan |
irinotecan analog affects the expression of GLRX3 mRNA | affects expression | 18927307
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of GLRX3 mRNA | increases expression | 17616710
|
D010656 |
Phenylephrine |
GLRX3 protein affects the susceptibility to Phenylephrine | affects response to substance | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK3 protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of MAPK8 protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCA protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCE protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
GLRX3 protein inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of PRKCZ protein] | decreases reaction|increases activity|increases phosphorylation | 16809552
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of GLRX3 mRNA | increases expression | 16809552
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of GLRX3 mRNA | increases expression | 19400957
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of GLRX3 mRNA | increases expression | 19400957
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of GLRX3 mRNA | decreases expression | 16788091
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of GLRX3 mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.81 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.18 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.18 | 14692618 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
6.78 | 10737359 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.78 | 6695378 10737359 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.88 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.77 | 16434500 19052882 18056438 17620307 17162532 19061943 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.51 | 15955085 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.71 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.00 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.33 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.94 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.94 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.23 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.27 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.77 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.77 | 16197459 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.74 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.41 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.95 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.95 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.95 | 19066611 19142967 20390343 19084267 18821012 18351453 20005174 18855134 17242785 19011961 19289846 15668708 19288272 16202921 18425577 19155303 19059307 20135344 18997820 15565566 19244106 18629630 19103187 20544844 19410462 11161223 21138602 19189210 20859285 19221464 20065188 18815881 17440819 21152245 16818667 19115204 19487384 19200415 17049068 17893378 16873071 19189212 18984771 17261762 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.95 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.46 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.20 | 11589617 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.38 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
16.58 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.58 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
16.58 | 3084413 10737359 17761372 3581430 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
16.58 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
16.58 | 15553829 14691202 11135700 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
16.58 | 19919837 18971187 16569478 20935162 3084413 11831363 18788625 16779866 18393292 19519916 18506893 17428255 10672840 21159647 19052882 20512989 17978847 19822196 19701751 3581430 17055752 18785209 20514400 19418558 16288022 10737359 19171122 18665156 19208518 19394651 19539802 16807293 18210153 16681979 17138121 18691550 16935385 20084675 17761372 18056438 20727157 20524982 17173139 19335982 16878318 20007298 20214788 20432363 19383236 16698587 18978308 17162532 18494052 16328049 16540662 16830150 16502159 19107877 20101231 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
16.58 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
16.58 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.86 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.75 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.00 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.25 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.50 | 17572228 |
MESH:D006332 |
Cardiomegaly |
therapeutic |
|
| 16809552 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
3.46 | 16170337 15728586 11179087 17124262 11754973 17287366 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.97 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.97 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.63 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.63 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.63 | 17174075 21159647 7505956 2727394 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.46 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.57 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.45 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.45 | 15861022 11677210 17333356 16919318 17110522 17681005 16105132 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.57 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.57 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.65 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.65 | 17159606 15273666 16391804 17454858 18259882 16303861 18509181 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.06 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.64 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.64 | 9664655 16925845 8800419 9224671 9125849 10589399 9142499 14991402 9211117 17551590 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.46 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.46 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.97 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.23 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.16 | 20387270 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.36 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
11.61 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.61 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.61 | 17906064 11834606 10663392 14986274 10915739 11461765 12705907 18071297 11287661 16227642 11529661 19416960 15619225 16109766 12540782 14725611 17562736 16781746 18713872 17522070 16485898 11421492 19085960 19739265 19164858 12958197 11739529 16081117 19370779 15968718 12594235 16393943 16177239 19923254 12153990 10774834 14550746 12392966 19420014 2444490 11743745 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
cyanoginosin LR |
11.61 | 17654400 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
11.61 | 19107877 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.97 | 19426721 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.34 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.52 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.52 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.15 | 19155303 16202921 17893378 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.15 | 16569247 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.99 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.61 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
4.61 | 15547733 15623463 16510608 16704527 15264214 15150132 15878914 16805852 15547721 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.48 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
23.36 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
23.36 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
23.36 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
23.36 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
23.36 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.16 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.40 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.05 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.26 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.26 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.13 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.55 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.09 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.92 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.10 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.83 | 14991402 9664655 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.19 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.29 | 6705139 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.29 | 15720958 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.28 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.28 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.44 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.21 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
5.21 | 8949925 12717712 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.43 | 12791704 18502941 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.68 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.34 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.40 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.98 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
7.98 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.98 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.20 | 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.64 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.78 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.55 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.55 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
16.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
16.85 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
16.85 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.92 | 16316344 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.13 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.13 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.67 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.18 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.33 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.07 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.07 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.80 | 16467208 20471514 19850784 17050201 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.80 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.35 | 12018890 16823087 15622746 11161223 17869043 17649720 16331271 17107899 17217047 16891316 15748426 17712046 12679006 19642359 15336539 19035177 16330433 9834237 16966277 19075265 19225113 15213294 11468182 12712474 16112521 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.35 | 15748426 17294898 17217047 16823087 17301526 17107899 16140955 17361223 12679006 19075265 17368321 17339181 19642359 16891316 19035177 17712046 16935935 9834237 19225113 17649720 16331271 16788101 16766008 19029980 17506722 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.22 | 16882451 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.21 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.06 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.75 | 18665156 18407596 20032147 18522880 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.45 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.45 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.79 | 19014921 12587719 12969438 16611625 19460945 16610002 19784758 11587558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.79 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.12 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.35 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
17.35 | 10672840 11376686 16273603 14678523 18001218 10737359 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
17.35 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
17.35 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
17.35 | 19255062 19090486 20583210 19073162 15885732 2422723 19996281 21047994 21167192 19642983 20101389 21071580 18648771 10737359 19254457 9163691 18754104 19551842 12771043 20118626 20137499 18978307 19690152 19850985 18977376 20405173 15175105 20434301 18644402 20501860 12112319 2862719 19426721 19256749 20452335 16942905 19833225 20492335 19812893 19427195 19294768 19638242 21278145 19499222 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
17.35 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
13.51 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
13.51 | 6150874 534488 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
13.51 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.51 | 18253720 18775883 3124819 18093689 17942915 19539802 2563599 18079962 17174075 19009564 9362446 18544905 17854601 16267830 19126423 16842330 19004024 18308698 19519916 18282651 18164116 21159647 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.25 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
4.77 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
4.77 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.77 | 20970405 20512841 21163286 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.77 | 18625569 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.63 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.54 | 11731420 16827153 14580682 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.42 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.73 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.21 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.21 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.05 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.44 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.29 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.66 | 16801185 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.88 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.01 | 19417148 14977855 19549372 15949261 11468182 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.54 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.14 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.14 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.91 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.91 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.83 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.25 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
9.25 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.25 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.35 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.87 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.17 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.37 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.37 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.02 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.02 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.41 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.82 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.82 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.60 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.99 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.50 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.50 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.70 | 17882678 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.86 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.74 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.74 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.23 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.23 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
8.34 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.34 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.34 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.56 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.04 | 19927285 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.57 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.57 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.82 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.62 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.62 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.62 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.48 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.18 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.66 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.65 | 10548101 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.98 | 16116481 16283617 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.83 | 16646077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.57 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.57 | 18551238 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.57 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.60 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.60 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.13 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.13 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.91 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
6.27 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
6.27 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
6.27 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
6.27 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.27 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.85 | 16045194 16684133 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.50 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.04 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
11.40 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.40 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.40 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.67 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.83 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.15 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
15.27 | 1399818 15289314 15867355 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.27 | 12973940 20435036 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.27 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.55 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.55 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.85 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.56 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.88 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.17 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.48 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.85 | 1336536 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.42 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.93 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.85 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.31 | 17120751 |